Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1981-07-27
1984-05-15
Coughlan, Jr., Paul M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
548252, C07D25704, A61K 3141
Patent
active
044487819
ABSTRACT:
The N-(substituted benzyl) imidazoles are selective enzyme inhibitors and thus are useful in the treatment of heart disease, circulatory and vascular problems.
REFERENCES:
patent: 3498999 (1970-03-01), Buchanan et al.
patent: 4118487 (1978-10-01), Regal et al.
patent: 4183742 (1980-01-01), Sasse et al.
Buchanan et al., J. Med. Chem., vol. 12, Nov. 1969, p. 1001.
Tai et al., "Biochemical and Biophysical Res. Comm., vol. 80, No. 1, 1978, pp. 235-243.
Johnson et al., J. Med. Chem. 12, 1024 (1969).
Baggaley et al., J. Med. Chem. 18, 833 (1975).
Cross Peter E.
Dickinson Roger P.
Coughlan, Jr. Paul M.
Pfizer Inc.
Springer D. B.
LandOfFree
N-Benzyl-imidazoles as selective inhibitors of the thromboxane s does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-Benzyl-imidazoles as selective inhibitors of the thromboxane s, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-Benzyl-imidazoles as selective inhibitors of the thromboxane s will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-844739